GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Other Operating Expense

Y-Biologics (XKRX:338840) Other Operating Expense : ₩-415 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Other Operating Expense?

Y-Biologics's Other Operating Expense for the three months ended in Mar. 2024 was ₩1,094 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-415 Mil.

Y-Biologics's quarterly Other Operating Expense increased from Sep. 2023 (₩-1,204 Mil) to Dec. 2023 (₩-304 Mil) and increased from Dec. 2023 (₩-304 Mil) to Mar. 2024 (₩1,094 Mil).

Y-Biologics's annual Other Operating Expense increased from Dec. 2020 (₩3,544 Mil) to Dec. 2021 (₩5,308 Mil) and increased from Dec. 2021 (₩5,308 Mil) to Dec. 2022 (₩6,719 Mil).

Y-Biologics Other Operating Expense Historical Data

The historical data trend for Y-Biologics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Other Operating Expense Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Operating Expense
Get a 7-Day Free Trial 1,578.78 2,584.02 3,544.15 5,307.72 6,718.70

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only - - -1,203.96 -304.44 1,093.67

Y-Biologics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-415 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Y-Biologics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Other Operating Expense
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Website
https://www.ybiologics.com
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines